211 related articles for article (PubMed ID: 2013146)
1. Screening for total cholesterol. Do the National Cholesterol Education Program's recommendations detect individuals at high risk of coronary heart disease?
Bush TL; Riedel D
Circulation; 1991 Apr; 83(4):1287-93. PubMed ID: 2013146
[TBL] [Abstract][Full Text] [Related]
2. Screening with total cholesterol: determining sensitivity and specificity of the National Cholesterol Education Program's guidelines from a population survey.
Gelskey DE; Young TK; MacDonald SM
J Clin Epidemiol; 1994 May; 47(5):547-53. PubMed ID: 7730880
[TBL] [Abstract][Full Text] [Related]
3. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
[TBL] [Abstract][Full Text] [Related]
5. Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.
Hecht HS; Superko HR
J Am Coll Cardiol; 2001 May; 37(6):1506-11. PubMed ID: 11345357
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
Tóth PP; Potter D; Ming EE
J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
[TBL] [Abstract][Full Text] [Related]
7. Screening for dyslipidemia. Practice parameter.
Hostetter AL
Am J Clin Pathol; 1995 Apr; 103(4):380-5. PubMed ID: 7726130
[TBL] [Abstract][Full Text] [Related]
8. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
9. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
Muntner P; Lee F; Astor BC
Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
[TBL] [Abstract][Full Text] [Related]
10. Direct measurement of low-density-lipoprotein cholesterol is more effective than total cholesterol for the purpose of lipoprotein screening.
Okada M; Ishida R
Prev Med; 2001 Mar; 32(3):224-9. PubMed ID: 11277679
[TBL] [Abstract][Full Text] [Related]
11. Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease.
Mailander L; Lavie CJ; Milani RV; Gaudin D
South Med J; 1993 May; 86(5):508-12. PubMed ID: 8488395
[TBL] [Abstract][Full Text] [Related]
12. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
13. New recommendations for the diagnosis and treatment of plasma lipid abnormalities.
Schaefer EJ
Nutr Rev; 1993 Aug; 51(8):246-53. PubMed ID: 8302497
[TBL] [Abstract][Full Text] [Related]
14. Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?
Correll CU; Kane JM; Manu P
J Clin Psychiatry; 2008 Apr; 69(4):578-83. PubMed ID: 18370572
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol measures to identify and treat individuals at risk for coronary heart disease.
Natarajan S; Glick H; Criqui M; Horowitz D; Lipsitz SR; Kinosian B
Am J Prev Med; 2003 Jul; 25(1):50-7. PubMed ID: 12818310
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.
Laemmle P; Unger L; McCray C; Chalin M; Glueck CJ
J Lab Clin Med; 1989 Mar; 113(3):325-34. PubMed ID: 2926240
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
19. The place of HDL in cholesterol management. A perspective from the National Cholesterol Educational Program.
Grundy SM; Goodman DW; Rifkind BM; Cleeman JI
Arch Intern Med; 1989 Mar; 149(3):505-10. PubMed ID: 2645842
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
